Dividend Declaration (5844G)
May 13 2011 - 9:04AM
UK Regulatory
TIDMHIK
RNS Number : 5844G
Hikma Pharmaceuticals Plc
13 May 2011
Hikma Pharmaceuticals PLC
Final Dividend for 2010
LONDON, 13 May 2011 - Hikma Pharmaceuticals PLC ("the Company")
advises that at its Annual General Meeting of shareholders, held on
12 May 2011, the final dividend of 7.5 cents per share was approved
by shareholders. The dividend will be paid on 26 May 2011 to
shareholders on the register on 15 April 2011.
Shareholders who have elected to receive their dividend in
Pounds Sterling will receive approximately 4.6 pence per Ordinary
Share (exchange rate US$1.6278 to GBPGBP1).
- ENDS -
Enquiries:
Hikma Pharmaceuticals PLC
Henry Knowles
Company Secretary +44 20 7399 2670
Susan Ringdal
Investor Relations Director +44 20 7399 2670
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed pharmaceutical
products. Hikma's operations are conducted through three
businesses: "Branded", "Injectables" and "Generics". Hikma's
operations are based principally in the Middle East and North
Africa ("MENA") region, where it is a market leader and sells
across 17 countries, the United States and Europe. In 2010, the
Group achieved revenues of $731 million (2009 $637 million) and
profit attributable to shareholders was $99 million (2009 $78
million).
This information is provided by RNS
The company news service from the London Stock Exchange
END
DIVAJMJTMBMBBJB
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024